SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-02-005044
Filing Date
2002-11-14
Accepted
2002-11-14 16:59:39
Documents
3
Period of Report
2002-09-30

Document Format Files

Seq Description Document Type Size
1 ANTIGENICS INC. b44475aie10vq.htm 10-Q 174717
3 EX-99.1 RISK FACTORS b44475aiexv99w1.txt EX-99.1 31728
4 COURTESY PDF b44475aie10vqxpdfy.pdf 10-Q 287213
  Complete submission text file 0000950135-02-005044.txt   495409
Mailing Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111
Business Address 630 FIFTH AVENUE SUITE 2170 NEW YORK NY 10111 2123324774
ANTIGENICS INC /DE/ (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29089 | Film No.: 02825938
SIC: 2836 Biological Products, (No Diagnostic Substances)